Clinical characteristics and risk factors of severe hyponatremia in cirrhotic patients treated with terlipressin.

What is known and objective: As terlipressin becomes more widely used in clinical practice, more papers had reported the correlation between hyponatremia and terlipressin treatment. This study was performed to evaluate the clinical characteristics and risk factors of severe hyponatremia in cirrhotic...

Full description

Bibliographic Details
Published in:Journal of Clinical Pharmacy & Therapeutics Vol. 45; no. 1; pp. 191 - 199
Main Authors: Pan, Xiaofeng, Zhou, Ziye, Jin, Xiangxiang, Shi, Dawei
Format: research tables/charts Journal Article
Published: Wiley-Blackwell Feb2020
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141002028&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 141002028
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        02694727
        EV4
      jtl: Journal of Clinical Pharmacy & Therapeutics
      issn: 02694727
      maglogo: Y
    pubinfo:
      dt: Feb2020
      vid: 45
      iid: 1
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        141002028
        141002028
        141002028
        10.1111/jcpt.13057
        141002028
      ppf: 191
      ppct: 8
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Clinical characteristics and risk factors of severe hyponatremia in cirrhotic patients treated with terlipressin.
      aug:
        au:
          Pan, Xiaofeng
          Zhou, Ziye
          Jin, Xiangxiang
          Shi, Dawei
        affil: Department of Pharmacy, First Affiliated Hospital of Wenzhou Medical University, Wenzhou China
      sug:
        subj:
          Hyponatremia Symptoms
          Hyponatremia Risk Factors
          Liver Cirrhosis Drug Therapy
          Vasopressins Adverse Effects
          Human
          Retrospective Design
          Peptic Ulcer Drug Therapy
          Gastrointestinal Hemorrhage Drug Therapy
          Sodium Blood
          Statistical Significance
          Albumins Blood
          Creatinine Blood
          Logistic Regression
          Odds Ratio
          Confidence Intervals
      ab: What is known and objective: As terlipressin becomes more widely used in clinical practice, more papers had reported the correlation between hyponatremia and terlipressin treatment. This study was performed to evaluate the clinical characteristics and risk factors of severe hyponatremia in cirrhotic patients treated with terlipressin and the effects of concomitant drugs. Methods: We conducted a retrospective evaluation of patients with cirrhosis treated with terlipressin at the gastroenterology department of Hospital between 1 January 2016 and 30 June 2018. Patients treated with terlipressin for gastrointestinal bleeding due to peptic ulcer and other non‐hepatic factors were excluded. Results and discussion: After the patients received terlipressin, their serum sodium concentrations decreased from 138.2 ± 4.3 mmol/L to 129.3 ± 7.2 mmol/L. Statistically significant differences were observed with respect to sex, initial serum sodium concentration, lowest serum sodium concentration, hyponatremia duration and total drug dose. Among the patients with hyponatremia, statistically significant differences in albumin level, serum creatinine level, hyponatremia duration and total drug dose were found between the patients with severe hyponatremia and those with non‐severe hyponatremia. Logistic regression analysis revealed that initial serum sodium concentration (odds ratio, 95% confidence interval: 18.475, 3.967–86.035; P =.000) was a risk factor for reduced serum concentration, and that albumin level (1.105, 1.012–1.207; P =.026), serum creatinine level (0.975, 0.952–0.997; P =.028) and hyponatremia duration (1.297, 1.064–1.583; P =.010) were risk factors of severe hyponatremia. What is new and conclusion: The incidence of severe hyponatremia among patients with cirrhosis who are treated with terlipressin is high. Moreover, higher initial serum sodium concentrations and increased duration of terlipressin administration are associated with a higher the incidence of severe hyponatremia. The initial albumin level is a risk factor for severe hyponatremia as is serum creatinine, although the latter is negatively correlated with the occurrence of the condition.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N